His scientific interests lie mostly in Plasminogen activator, Molecular biology, Biochemistry, Serpin and Endocrinology. His work on Plasminogen activator inhibitor-1 as part of general Plasminogen activator research is often related to Sodium, thus linking different fields of science. His research integrates issues of Cell culture, Cell and Peptide sequence, Gene, Signal peptide in his study of Molecular biology.
In general Biochemistry, his work in Reactive center, Escherichia coli, Enzyme and Plasma protein binding is often linked to Vitronectin linking many areas of study. In his study, Biophysics, Inhibitory postsynaptic potential and Fluorescence anisotropy is inextricably linked to Protease, which falls within the broad field of Serpin. He focuses mostly in the field of Endocrinology, narrowing it down to matters related to Internal medicine and, in some cases, Plasmin.
Tor Ny mainly investigates Plasminogen activator, Internal medicine, Endocrinology, Molecular biology and Biochemistry. His Plasminogen activator study combines topics from a wide range of disciplines, such as Serpin, Plasmin and Urokinase. Tor Ny has included themes like Protease, Stereochemistry, Mutant and Cell biology in his Serpin study.
His research investigates the connection between Internal medicine and topics such as Proteases that intersect with problems in Follicular phase. His work focuses on many connections between Molecular biology and other disciplines, such as Complementary DNA, that overlap with his field of interest in Antibody. His work on Enzyme, Escherichia coli, Reactive center and Wild type is typically connected to Vitronectin as part of general Biochemistry study, connecting several disciplines of science.
His main research concerns Wound healing, Inflammation, Cancer research, Plasmin and Plasminogen activator. His Wound healing research is multidisciplinary, incorporating elements of Fibroblast, Cell biology and Fibrin. His Inflammation research is multidisciplinary, incorporating perspectives in Tumor necrosis factor alpha and Tympan.
Tor Ny has researched Plasmin in several fields, including Host, Immunology, Microbiology and Staphylococcus aureus. Tor Ny is investigating Endocrinology and Internal medicine as part of his examination of Plasminogen activator. His work on Ovarian follicle, Granulosa cell and Follicular atresia as part of general Endocrinology study is frequently linked to Serine/threonine-specific protein kinase, therefore connecting diverse disciplines of science.
Tor Ny mainly focuses on Immunology, Wound healing, Plasmin, Plasminogen activator and Proinflammatory cytokine. His Wound healing study which covers Fibroblast that intersects with Paracrine signalling and Cell biology. His Plasmin study deals with Staphylococcus aureus intersecting with Rheumatology and Enzyme.
Tor Ny works mostly in the field of Rheumatology, limiting it down to topics relating to Microbiology and, in certain cases, Internal medicine. His biological study spans a wide range of topics, including Tumor necrosis factor alpha, Periodontitis, Dental alveolus, Sepsis and Survival rate. His studies in Proinflammatory cytokine integrate themes in fields like Systemic administration, Interleukin 6, Cytokine, Diabetes mellitus and Long-term potentiation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fluorescence and Absorption Spectroscopic Properties of Dipyrrometheneboron Difluoride (BODIPY) Derivatives in Liquids, Lipid Membranes, and Proteins
Jan Karolin;Lennart B.-A. Johansson;Leif Strandberg;Tor Ny.
Journal of the American Chemical Society (1994)
The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.
Tor Ny;Fredrik Elgh;Bjorn Lund.
Proceedings of the National Academy of Sciences of the United States of America (1984)
Dimers of Dipyrrometheneboron Difluoride (BODIPY) with Light Spectroscopic Applications in Chemistry and Biology
Fredrik Bergström;Ilya Mikhalyov;Peter Hägglöf;Rüdiger Wortmann.
Journal of the American Chemical Society (2002)
Localization of Luteinizing Hormone Receptor Messenger Ribonucleic Acid Expression in Ovarian Cell Types during Follicle Development and Ovulation
Xiao-Rong Peng;Aaron J. W. Hsueh;Philip S. Lapolt;Lars Bjersing.
Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-β–Slug signaling
Fang Cheng;Yue Shen;Ponnuswamy Mohanasundaram;Michelle Lindström.
Proceedings of the National Academy of Sciences of the United States of America (2016)
Cultured granulosa cells produce two plasminogen activators and an antiactivator, each regulated differently by gonadotropins.
Tor Ny;Lars Bjersing;Aaron J.W. Hsueh;David J. Loskutoff.
The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex.
Malgorzata Wilczynska;Ming Fa;Per-Ingvar Ohlsson;Tor Ny.
Journal of Biological Chemistry (1995)
Purification and Characterization of a Melanoma Cell Plasminogen Activator
Per Wallén;Gunnar Pohl;Nils Bergsdorf;Mats Rånby.
FEBS Journal (1983)
Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins.
Malgorzata Wilczynska;Ming Fa;Jan Karolin;Per-Ingvar Ohlsson.
Nature Structural & Molecular Biology (1997)
Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
Daniel A. Lawrence;Leif Strandberg;Johan Ericson;Tor Ny.
Journal of Biological Chemistry (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: